Mastocytosis - 83 Studies Found
Completed |
: Midostaurin in Indolent Systemic Mastocytosis : Indolent Systemic Mastocytosis : 2013-08-07 : Drug: Midostaurin, Midostaurin, twice daily 100 mg orally, continuously for 6 months |
Completed |
: Stem Cell Transplantation to Treat Systemic Mastocytosis : Mastocytosis : 2000-10-17 : Procedure: Stem cell transplantation |
Completed |
: Use of Tamoxifen in Systemic Mastocytosis : Systemic Mastocytosis : 2007-12-25 |
Completed |
: Evaluation of Response of Dasatinib to Treat Mastocytosis : Systemic Mastocytosis : 2009-09-16 : Drug: Dasatinib Starting dosage 20mg once daily, that can be escalated up to 100mg once daily. Patient w |
Completed |
: Masitinib in Patients With Mastocytosis With Handicap and Bearing the D816V Mutation : Patients With Mastocytosis With Handicap and Bearing Mutations Asp-816-Val (D816V) : 2010-12-23 : Drug: masitinib |
Completed |
: Treatment of Indolent Systemic Mastocytosis With PA101 :
|
Terminated |
: Obatoclax for Systemic Mastocytosis :
: 2009-06-09 : Drug: Obatoclax Mesylate 30 mg given by vein over 3 hours on Days 1-3 of each 14-day study cycle. |
Completed |
: Blood Factors in Mastocytosis and Unexplained Anaphylaxis and Flushing :
: 2002-10-22 |
Completed |
: Ontak (Denileukin Diftitox) in Patients With Systemic Mastocytosis (SM) :
: 2007-06-26 : Drug: Ontak (Denileukin Diftitox) 9 µg/kg by vein Days 1-5 of a 21 day cycle. |
Recruiting |
: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK002 : Indolent Systemic Mastocytosis : 2016-06-16 : Drug: AK002 |